An investigation into the relationship between carrier-based dry powder inhalation performance and formulation cohesive-adhesive force balances.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European journal of pharmaceutics and biopharmaceutics

• Publication date

  2008-06-01

• Fields of study

  Medicine, Materials Science, Engineering

• Identifiers
  DOI 10.1016/j.ejpb.2007.11.019PMID 18191553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• An Investigation into the Dispersion Mechanisms of Ternary Dry Powder Inhaler Formulations by the Quantification of Interparticulate Forces

  2008cited by this paper
• Influence of carrier on the performance of dry powder inhalers.

  2007cited by this paper
• Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.

  2007cited by this paper
• Comparative study of erythritol and lactose monohydrate as carriers for inhalation: atomic force microscopy and in vitro correlation.

  2006cited by this paper
• The Influence of Fine Excipient Particles on the Performance of Carrier-Based Dry Powder Inhalation Formulations

  2006cited by this paper
• Dehydration of trehalose dihydrate at low relative humidity and ambient temperature.

  2006cited by this paper
• Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach.

  2006cited by this paper
• Erythritol-based dry powder of glucagon for pulmonary administration.

  2005cited by this paper
• Use of recrystallized lactose as carrier for inhalation powder of interferon a2b.

  2005cited by this paper
• Carriers in drug powder delivery

  2005cited by this paper
• Effect of physical properties of carrier particles on drug emission from a dry powder inhaler device

  2005cited by this paper
• Alternative sugars as potential carriers for dry powder inhalations.

  2004cited by this paper
• The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy

  2004cited by this paper
• Dry powder inhalers for pulmonary drug delivery

  2004cited by this paper
• The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations II: Influence on Fine Particle Delivery Characteristics

  2004cited by this paper
• Formulation development of inhalation powders for FK888 with carrier lactose using Spinhaler and its absorption in healthy volunteers.

  2004cited by this paper
• The influence of carrier and drug morphology on drug delivery from dry powder formulations.

  2003cited by this paper
• Effects of carriers and storage of formulation on the lung deposition of a hydrophobic and hydrophilic drug from a DPI.

  2003cited by this paper
• Predicting the Quality of Powders for Inhalation from Surface Energy and Area

  2002cited by this paper
• Particulate Interactions in Dry Powder Formulations for Inhalation

  2000cited by this paper
• The use of different sugars as fine and coarse carriers for aerosolised salbutamol sulphate.

  2000cited by this paper
• The influence of carrier morphology on drug delivery by dry powder inhalers.

  2000cited by this paper
• Morphology of Crystals of α-Lactose Hydrate Grown from Aqueous Solution

  2000cited by this paper
• A study of drug-carrier interactions in dry powder inhaler formulations using the Andersen cascade impactor, X-ray microanalysis and time of flight aerosol beam spectrometry (TOFABS).

  2000cited by this paper
• The relationship between physical properties of lactose monohydrate and the aerodynamic behaviour of adhered drug particles

  1998cited by this paper
• Particle-Particle Adhesion in Pharmaceutical Powder Handling

  1998cited by this paper
• Dry powder formulations for pulmonary delivery

  1998cited by this paper
• Influence of excipients and storage humidity on the deposition of disodium cromoglycate (DSCG) in the Twin Impinger

  1996cited by this paper
• Cascade impaction methods for dry powder inhalers using the high flowrate Marple-Miller impactor

  1996cited by this paper
• The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation

  1996cited by this paper
• Drug delivery to the respiratory tract using dry powder inhalers

  1994cited by this paper
• THE GENERATION OF RESPIRABLE CLOUDS FROM COARSE POWDER AGGREGATES

  1992cited by this paper
• Advances in Pharmaceutical Sciences

  1982cited by this paper
• The Control of Humidity by Saturated Salt Solutions

  1948cited by this paper

• Cryo-Crystallization of Inhalable Budesonide Ultrafine Crystals with Enhanced Aerosol Performance: Mechanism and Evaluation.

  2025cites this paper
• Particle surface coating for dry powder inhaler formulations

  2025influential citation
• Scale-Up and Postapproval Changes in Orally Inhaled Drug Products: Scientific and Regulatory Considerations

  2024cites this paper
• Formulation strategies, preparation methods, and devices for pulmonary delivery of biologics.

  2024cites this paper
• Future of Carrier-Free Dry Powder Inhaler Formulations

  2024cites this paper
• Different Carriers for Use in Dry Powder Inhalers: Characteristics of Their Particles

  2024cites this paper
• Predicting the Strength of Cohesive and Adhesive Interparticle Interactions for Dry Powder Inhalation Blends of Terbutaline Sulfate with α-Lactose Monohydrate

  2023cites this paper
• The Optimisation of Carrier Selection in Dry Powder Inhaler Formulation and the Role of Surface Energetics

  2022cites this paper
• Recent developments in lactose blend formulations for carrier-based dry powder inhalation.

  2022cites this paper
• Engineered inhalable micro-balloon shaped drug particles for carrier-free dry powder inhalation (DPI) application

  2022cites this paper
• Crystallization induced flower-like lactose as potential carriers for dry powder inhaler application

  2022cites this paper
• The role of intrinsic fines in the performance change of expired lactose carriers for DPI applications.

  2022cites this paper
• Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder.

  2022cites this paper
• Remdesivir powders manufactured by jet milling for potential pulmonary treatment of COVID-19

  2022cites this paper
• Engineering the right formulation for enhanced drug delivery.

  2022cites this paper
• Physicochemical analysis techniques specialized in surface characterization of inhalable dry powders

  2021cites this paper
• Ex vivo and in vitro evaluation of the influence of the inhaler device and formulation on lung deposition of budesonide

  2020cites this paper
• Co-spraying of carriers (mannitol-lactose) as a method to improve aerosolization performance of salbutamol sulfate dry powder inhaler

  2020cites this paper
• Performance tuning of particle engineered mannitol in dry powder inhalation formulations.

  2020cites this paper
• The crucial role of leucine concentration on spray dried mannitol-leucine as a single carrier to enhance the aerosolization performance of Albuterol sulfate

  2019cites this paper
• Application of lactose in the pharmaceutical industry

  2019cites this paper
• Quality by Design Considerations for Product Development of Dry-Powder Inhalers

  2019cites this paper
• Effect of Dosing Cup Size on the Aerosol Performance of High-Dose Carrier-Based Formulations in a Novel Dry Powder Inhaler.

  2019cites this paper
• Particle engineered mannitol for carrier-based inhalation - a serious alternative?

  2019cites this paper
• Identification des contaminants présents à la surface de lactose à usage pharmaceutique et analyse de l’impact de leur présence sur les interactions avec différents principes actifs

  2018cites this paper
• Discrete element method based analysis of mixing and collision dynamics in adhesive mixing process

  2018cites this paper
• Influence of excipients on physical and aerosolization stability of spray dried high‐dose powder formulations for inhalation

  2018cites this paper
• The role of the solid state and physical properties of the carrier in adhesive mixtures for lung delivery

  2018cites this paper
• University of Groningen Induction of Encephalitis in Rhesus Monkeys Infused with Lymphocryptovirus-Infected B-Cells Presenting MOG(34-56) Peptide Haanstra,

  2018cites this paper
• Particle interactions in complex dry powder inhaled formulations and single particle aerosol mass spectrometry

  2018influential citation
• Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products.

  2018cites this paper
• Mechanistic investigation of mixing and segregation of ordered mixtures: experiments and numerical simulations

  2017cites this paper
• Particle interactions of fluticasone propionate and salmeterol xinafoate detected with single particle aerosol mass spectrometry (SPAMS).

  2017cites this paper
• Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.

  2017cites this paper
• Development of a Rational Design Space for Optimizing Mixing Conditions for Formation of Adhesive Mixtures for Dry-Powder Inhaler Formulations.

  2017cites this paper
• Comparison of the cohesion-adhesion balance approach to colloidal probe atomic force microscopy and the measurement of Hansen partial solubility parameters by inverse gas chromatography for the prediction of dry powder inhalation performance.

  2016influential citation
• Preformulation as an Aid to Product Design in Early Drug Development

  2016cites this paper
• Effect of lactose solid-state on the aerosolization performance of drug-carrier mixtures

  2016cites this paper
• Multivariate data analysis to assess dry powder inhalers performance from powder properties

  2016cites this paper
• Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.

  2016cites this paper
• Effect of Device Design and Formulation on the In Vitro Comparability for Multi-Unit Dose Dry Powder Inhalers

  2015cites this paper
• Mathematical approach for understanding deagglomeration behaviour of drug powder in formulations with coarse carrier

  2015cites this paper
• Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery

  2015cites this paper
• Improved Aerosol Deposition Profiles from Dry Powder Inhalers

  2015cites this paper
• Mechanical Activation of Secondary Processed Orally Inhaled Active Pharmaceutical Ingredients

  2015cites this paper
• Characterisation of dry powder inhaler formulations using atomic force microscopy.

  2015cites this paper
• Formulation pre-screening of inhalation powders using computational atom-atom systematic search method.

  2015cites this paper
• Recent advances in the fundamental understanding of adhesive mixtures for inhalation.

  2015cites this paper
• Quality by Design: Concept for Product Development of Dry‐powder Inhalers

  2015cites this paper
• The Influence of Secondary Processing on the Structural Relaxation Dynamics of Fluticasone Propionate

  2014influential citation
• Nanocrystal Recovery by Use of Carrier Particles

  2014cites this paper
• Defining the Critical Material Attributes of Lactose Monohydrate in Carrier Based Dry Powder Inhaler Formulations Using Artificial Neural Networks

  2014cites this paper
• Hyperspektral bildanalys av pulverblandningar innehållande mannitol och natriumsalicylat : Effekt av partikelstorlek och blandningstid

  2014cites this paper
• Budesonide dry powder for inhalation: effects of leucine and mannitol on the efficiency of delivery

  2014influential citation
• Engineering particle agglomeration in dry powder inhaler formulations to co-deliver drugs to the lungs

  2014cites this paper
• Research Article Formulation and Evaluation of Combination Dry Powder for Inhalation: Influence of Crystalline Excipient

  2013cites this paper
• Drug Content Effects on the Dispersion Performance of Adhesive Mixtures for Inhalation

  2013cites this paper
• Formulation and Evaluation of Combination Dry Powder for Inhalation: Influence of Crystalline Excipient

  2013cites this paper
• Blends of cross-linked high amylose starch/pectin loaded with diclofenac.

  2013cites this paper
• Characterising the force balance between active pharmaceutical ingredients for inhalation and its impact on deposition

  2013cites this paper
• Pharmaceutical development studies for inhalation products

  2013cites this paper
• Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalers.

  2013cites this paper
• Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction

  2013cites this paper
• apid characterisation of the inherent dispersibility of respirable powders using ry dispersion laser diffraction

  2013influential citation
• Importance of Powder Residence Time for the Aerosol Delivery Performance of a Commercial Dry Powder Inhaler Aerolizer®

  2012cites this paper
• Advanced microscopy techniques to assess solid-state properties of inhalation medicines.

  2012cites this paper
• A critical view on lactose-based drug formulation and device studies for dry powder inhalation: which are relevant and what interactions to expect?

  2012cites this paper
• Development of budesonide nanocluster dry powder aerosols: preformulation.

  2012cites this paper
• The use of inverse gas chromatography for the study of lactose and pharmaceutical materials used in dry powder inhalers.

  2012cites this paper
• Lactose characteristics and the generation of the aerosol.

  2012cites this paper
• The influence of physical properties and morphology of crystallised lactose on delivery of salbutamol sulphate from dry powder inhalers.

  2012cites this paper
• Influence of primary crystallisation conditions on the mechanical and interfacial properties of micronised budesonide for dry powder inhalation.

  2012cites this paper
• Thermal ink-jet spray freeze-drying for preparation of excipient-free salbutamol sulphate for inhalation.

  2012cites this paper
• The Effect of Engineered Mannitol-Lactose Mixture on Dry Powder Inhaler Performance

  2012cites this paper
• Physico-chemical aspects of lactose for inhalation.

  2012cites this paper
• Investigation into the Influence of Primary Crystallization Conditions on the Mechanical Properties and Secondary Processing Behaviour of Fluticasone Propionate for Carrier Based Dry Powder Inhaler Formulations

  2011cites this paper
• Interactions, structure and process: relevant aspects of the development of lactose-based formulations and devices for dry powder inhalation

  2011cites this paper
• SUSTAINED RELEASE OF SPRAY-DRIED COMBINATION DRY POWDER INHALER FORMULATION FOR PULMONARY DELIVERY Research Article

  2011cites this paper
• Particle Interactions in Dry Powder Inhaler Unit Processes: A Review

  2011cites this paper
• Micronized Drug Adhesion and Detachment from Surfaces: Effect of Loading Conditions

  2011cites this paper
• In Vitro Performance Testing for Pulmonary Drug Delivery

  2011cites this paper
• Improved aerosolization performance of salbutamol sulfate formulated with lactose crystallized from binary mixtures of ethanol-acetone.

  2011cites this paper
• Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.

  2010cites this paper
• Heterogeneous particle deaggregation and its implication for therapeutic aerosol performance.

  2010cites this paper
• Engineering of combination particles for improved therapeutic efficacy

  2010cites this paper
• The relationship between drug concentration, mixing time, blending order and ternary dry powder inhalation performance.

  2010cites this paper
• Characterisation and functionality of inhalation anhydrous lactose.

  2010cites this paper
• Investigation of Electrostatic Properties of Pharmaceutical Powders Using Phase Doppler Anemometry

  2010cites this paper
• Engineering of particles for inhalation

  2009cites this paper
• Engineering of Crystalline Combination Inhalation Particles of a Long-Acting β2-agonist and a Corticosteroid

  2009cites this paper
• Rapid preformulation screening of drug candidates for dry powder inhaler preparation

  2008cites this paper